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ABSTRACT We have studied the genetic segregation of
human T-cell receptor .l-chain (TCRf) genes on chromosome 7q
in 40 CEPH (Centre d'Etude du Polymorphisme Humain)
families by using restriction fragment length polymorphisms
(RFLPs). We constructed haplotypes from eight RFLPs by using
variable- and constant-region cDNA probes, which detect poly-
morphisms that span more than 600 kilobases of the TCRN gene
complex. Analysis of allele distributions between TCR23 genes
revealed significant linkage disequilibrium between only 6 ofthe
28 different pairs of RFLPs. This linkage disequilibrium
strongly influences the most efficient order to proceed for typing
of these RFLPs in order to achieve maximum genetic informa-
tiveness, which in this study revealed a 97.3% level of heterozy-
gosity within the TCRI3 gene complex. Our results should
provide new insight into recent reports of disease associations
with the TCRfi gene complex and should assist in designing
future experiments to detect or confirm the existence of disease-
susceptibility loci in this region of the human genome.
The human T-cell receptor 8-chain (TCRP) locus is a gene
complex containing variable (V), diversity (D), and joining (J)
gene segments that participate in somatic cell rearrangement
with a constant (C) gene to encode the 8-chain of the T-cell
receptor (1). By in situ hybridization, the TCR/3 locus resides
at chromosomal band 7q35 (2), with the C gene telomeric to the
V-region genes (3). By current estimates, this complex spans
more than 600 kilobases (kb) of DNA and contains 70-80
V-region segments (4-7). Following successful DNA rear-
rangement of the V, D, and J gene segments, the translated
p8-chain polypeptide pairs with a T-cell receptor a chain and
can be expressed on the surface of the T cell (reviewed in ref.
8). The T-cell receptor then functions in recognizing antigen in
the context of a self major histocompatibility molecule (9).
Since T cells play a pivotal role in the differentiation and
regulation of effector mechanisms within the immune system
(10), it has been postulated that variations in the germ-line
TCR,3 repertoire might contribute to certain disease suscep-
tibilities. Such theories have recently been tested by studying
germ-line DNA polymorphisms ofthe a and p chain in normal
and disease populations (reviewed in refs. 11 and 12). Positive
associations have been reported between specific TCR,/ re-
striction fragment length polymorphisms (RFLPs) and human
autoimmune diseases (13-20). While these positive associa-
tions are based on TCR/3 RFLP frequency comparisons be-
tween populations, for multiple sclerosis the TCRI3 associa-
tion has been confirmed by a sib-pair analysis (21).
In this report we present our results of tracing the inher-
itance of eight TCR,8 RFLPs through 40 large CEPH (Centre
d'Etude du Polymorphisme Humain) pedigrees. As a result of
this study, we have determined the usefulness of each of
these polymorphisms individually, and in combination, for
the purposes of future investigations into the contributing
role of the TCR8 genes to disease susceptibility. We have
measured the nonrandom association (i.e., linkage disequi-
librium) between the eight RFLPs. We have also demon-
strated the utility of these TCR,8 RFLPs for genetic linkage
analyses by constructing a genetic map of this region of the
long arm ofchromosome 7 with the TCR,8 locus in the middle
of this map.
MATERIALS AND METHODS
DNA Probes. Cloned cDNA segments for the Van, V,97.2,
Vp8.2, and Vp311 gene segments (4) as well as the C13 (23) and
Vp315 (5) gene segments were employed in detecting RFLPs.
Southern Blot Analysis. Southern blot analyses were car-
ried out as described (12).
Pedigrees Analyzed. DNA was isolated from lymphoblas-
toid B-cell lines from the 40 CEPH families (24). These
pedigrees include over 500 individuals (primarily Northern
European Caucasians) with approximately 700 potentially
informative meioses available for segregation analysis.
CEPH genotypes for the probe/enzyme system MET/Taq I
were submitted to the CEPH data base by the laboratories of
R. Williamson (London) and R. White (Salt Lake City).
CEPH genotypes for the "CRI" probe/enzyme systems
were submitted by Collaborative Research. Typing of all
TCR,3 RFLPs was performed by us, and the genotypes
collected will be part of the CEPH Version 3 and/or Version
4 data bases.
Statistical Analysis. The extent of nonrandom allelic asso-
ciation, or linkage disequilibrium, between the TCR,8 poly-
morphisms examined was calculated using the test statistic
Q, as suggested by Hedrick et al. (25).
The percent heterozygosity of every possible grouping of
loci for the CEPH parents was tabulated by using a computer
program written in dBASEIII. Linkage analysis was per-
formed using the computer program MENDEL (26, 27). La-
louel's least-squares criterion was used to generate 40 can-
didate orders (28). Maximum multipoint logarithm of odds
(lod) scores were then computed for each of the identified
candidate orders to find the most likely multipoint order.
RESULTS
DNA Polymorphisms and Haplotype Construction. EcoRV
restriction digests of DNA from the CEPH parents revealed
an RFLP detected with the V,97 probe. This Vs7/EcoRV
RFLP is biallelic with polymorphic restriction fragments of
Abbreviations: CEPH, Centre d'Etude du Polymorphisme Humain;
RFLP, restriction fragment length polymorphism; TCR,8, T-cell
receptor ,8 chain; V, variable; D, diversity; J, joining; C, constant;
lod, logarithm of odds; cM, centimorgan(s).
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FIG. 1. Demonstration of the codominant segregation of a pre-
viously unreported EcoRV polymorphism detected with a V07
probe. Two alleles are detected, (i) 23 kb and (ii) 20.5 and 3.9 kb, as
indicated at right (monomorphic bands are designated with an
asterisk). Electrophoretic size standards are in the left-most lane and
identified according to molecular size in kilobases.
either 23 kb, or 20.5 and 3.9 kb, as demonstrated by the
Mendelian segregation in Fig. 1. Descriptions of the Cs/Bgl
II (29), Cs/Kpn I (30), V,98/BamHI (31), V911/BamHI (31),
V31/Taq I (12), V,07/BamHI (12), and V,015/Msp I (22)
RFLPs have been reported. These TCRf3 RFLPs are sum-
marized in Table 1. The observed genotype distribution of
these TCR,8 RFLPs in the CEPH pedigrees did not differ
significantly from the distribution predicted assuming Har-
dy-Weinberg equilibrium (P > 0.01). Because of the struc-
ture of the CEPH pedigrees-i.e., mostly three-generation
with large sibships-parental haplotypes were unambig-
uously determined for all of these probe/enzyme systems.
Nonrandom Ailelic Association (Linkage Disequilibrium).
We tested for the presence of significant linkage disequilib-
rium between each pair of polymorphisms by comparing the
overall distribution of the two-locus haplotypes observed as
compared to the haplotype distribution expected assuming
random allelic association (Table 2). When the extent of
linkage disequilibrium was converted into P values and the
level of significance (P c 0.01) was corrected for the 28
pairwise comparisons made, significant linkage disequilib-
rium was found amongst the RFLPs. We noted very strong
disequilibrium (P c 10-19) between several pairs of loci,
including V137/EcoRV with V137/BamHI, V,98/BamHI with
V,311/BamHI, V138/BamHI with V,915/Msp I, and V911/
BamHI with V,015/Msp I. We also observed some level ofdisequilibrium between Vp7/EcoRV and Vl1/Taq I and
between V,7/BamHI and V,98/BamHI, but these were below
the level of uncorrected statistical significance of P s 0.01
(but were not statistically significant when corrected for the
number of comparisons made). Despite the extreme levels of
nonrandom allelic association, we noted only one case of
''complete" linkage disequilibrium between any pair of
markers: with V611/BamHI and V,015/Msp I, the first Vp11
allele (25 kb) was always found with the third V1315 allele (5.5
kb), and the second V911 allele (20 kb) always occurred with
the second V,15 allele (6.3 kb) (Table 1). These V1311 and
Vp15 genes are within 20 kb of one another (unpublisheddata).
There is a conspicuous absence of linkage disequilibrium
between the Bgl II and Kpn I C,3 RFLPs. These sites are only
1.8 kb apart (30). Consistent with this observation, V915/Msp
I is the only Vp RFLP in disequilibrium with Cs/Bgl II, yet
V,915/Msp I is not in disequilibrium with the Cs/Kpn I
polymorphism (Fig. 2).
Strategies for Achieving Maximum Heterozygosity. In at-
tempts to characterize the segregation of the TCR,3 complex
in many pedigrees, it may not be feasible or necessary to
determine genotypes for all eight RFLPs (Table 1). The
presence of linkage disequilibrium among these RFLPs im-
plies that there may be overlap in their heterozygosities. We
therefore tabulated the level of heterozygosity achieved by
every possible set ofthe six restriction enzymes tested (Table
3). For any single restriction enzyme, BamHI has the best
likelihood (82.4%) of distinguishing the two TCRF chromo-
somes in any given individual. While BamHI detects three
different TCR,8 RFLPs (V,7, V,8, and V,011), the 82.4% level
of heterozygosity was achieved by probing with only V,7 and
V,8. (Fortuitously, the BamHI restriction fragments de-
tected on the Southern blot with V,7 and V,8 probes do not
Table 1. DNA polymorphisms studied within the TCR,3 complex
No. of
Fragment % allele % observed individuals
Probe Enzyme Allele size(s), kb frequency* heterozygosity* typed
V/37 EcoRV 1 23.0 38 49 211
2 20.5, 3.9 62
Vp7 BamHI 1 13.0, 8.4 60 63 404
2 12.3 26
3 7.8 14
V81 Taq I 1 3.9 18 26 308
2 3.3 82
V68.2 BamHI 1 23.0 51 54 468
2 2.0 49
VP11 BamHI 1 25.0 47 51 472
2 20.0 53
V,015 Msp I 1 8.1 29 64 339
2 6.3 52
3 5.5 19
Can Bgl II 1 10.0 57 52 470
2 9.0 43
Cat Kpn I 1 6.9 49 47 280
2 1.9 51
*Based on the parental genotypes.
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Table 2. Linkage disequilibrium between TCR,8 polymorphisms
Vp7/EcoRV Vp7/BamHI V,1/Taq I Vp8/BamHI V,11/BamHI Vp15/Msp I Cp/Bgl II Cp/Kpn I
Vp37/EcoRV jp-19 0.0004 0.59 0.85 0.78 0.21 0.70
Vp37/BamHI 127 1Q- 0.009 0.29 0.15 0.06 0.98
V31/Taq I 132 184 0.68 0.80 0.97 0.51 0.24
V,38/BamHI 145 220 197 ifL±3 lo-22 0.39 0.46
V311/BamHI 140 217 1% 223 10-33 0.04 0.46
VP15/Msp I 123 168 158 161 153 10-8 0.39
C,3/Bgl II 149 228 203 227 226 180 0.014
C,3/Kpn I 122 165 169 178 178 149 167
Linkage disequilibrium among the unrelated CEPH Caucasian founders as measured by the Q statistic described by Hedrick et al. (30).
Uncorrected P values are shown above the diagonal and are based on the x2 distribution of Q. The extent of linkage disequilibrium between
adjacent RFLPs can be read immediately above the diagonal and are underlined. Degrees of freedom for each pair of loci are calculated by
multiplying the number of alleles minus one that are present at each locus (Table 1). The P level for significant disequilibrium should be corrected
for the number of comparisons made-i.e., P = 0.01 + 28 = 0.00036. P values below this level of significance are in italic type. The numbers
of haplotypes examined are shown below the diagonal.
overlap with one another and can be hybridized simultane-
ously in a single experiment.) When all 15 possible sets oftwo
restriction enzymes were surveyed for heterozygosity, a
maximum of91.9% informativeness was achieved by hybrid-
izing the BamHI and Bgl II Southern blots (Table 3); these
blots would thus be probed with V,07 and Vp8, and with C,.
Though not listed, the combination of BamHI and Kpn I
digests yielded 90.5% heterozygosity. When each of the 20
possible combinations of three restriction digests were ex-
amined, BamHI, Bgl II, and Kpn I blots yielded a maximal
level of heterozygosity, 97.3%. No additional heterozygosity
was achieved using the remaining restriction digests.
Genetic Linkage Analysis Using the TCRfi Complex. The
TCR, haplotypes constructed from the eight probe/enzyme
systems in Table 1 were used for analysis of linkage with 39
markers on chromosome 7 in the CEPH Version 2 genotype
data base. Because of the informativeness of the TCRt3
haplotypes, statistically significant lod scores (>3.0) resulted
from linkage with genetic markers located more than 25
centimorgans (cM) away (by pairwise analyses), e.g., MET
and D7S104. Segregation data from seven 7q markers on
CEPH families were also subjected to multipoint analysis.
The resulting "most likely map" extended in both directions
from the TCRj3 complex for a total distance of more than 60
cM (Fig. 3). The map is oriented with the met protooncogene
homolog centromeric based on its tight linkage with the cystic
fibrosis locus (0.4% recombination) (33), which has recently
been localized to chromosome 7q31 (34). The TCR/3 complex
is telomeric to the cystic fibrosis locus, having been physi-
cally mapped by in situ hybridization to band 7q35 (2).
DISCUSSION
While calculation of linkage disequilibrium cannot always be
used to establish the physical distance between markers due to
recombination hotspots in the human genome (22), linkage
disequilibrium can be helpful in establishing the relative order
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of markers. Our estimates of linkage disequilibrium between
the eight RFLPs roughly correlate with the physical order of
these RFLPs as seen in Fig. 2, and as listed in order across
Table 2. Perhaps the most surprising pairwise comparison
measured is the lack ofdisequilibrium between the adjacent Cp
RFLPs detected with BgI II and Kpn I. Despite a known
physical separation of 1.8 kb (30), these RFLPs are not in
significant linkage disequilibrium. This observation could be
explained if a recombination hotspot were located between
these two RFLPs. In contrast, the V,98/BamHI and V,11/
BamHI polymorphisms showed very significant disequilib-
rium and are physically separated by approximately 180 kb (7).
While significant disequilibrium occurs between five of the
seven adjacent pairs of RFLPs, we noted only one instance
of significant disequilibrium between a nonadjacent pair
(Vq8/BamHI with V,315/Msp I) out of 21 comparisons made
between nonadjacent pairs. This indicates that while there is
indeed measurable linkage disequilibrium within the TCRP
complex, the disequilibrium becomes quite reduced over
greater distances within the gene complex, presumably due to
hotspots for meiotic recombination. It is likely that careful
analysis of any chromosomal region will similarly reveal
hotspots for recombination, as revealed by linkage disequi-
librium measurements.
Our observations of random association between the ma-
jority of the nonadjacent pairs ofRFLPs examined herein has
important implications for interpreting TCR,8/disease asso-
ciation studies. First, disease association studies that only
examine RFLPs within the C region of the TCRf3 complex
cannot draw conclusions regarding the possibility of suscep-
tibility loci that might lie within all but the most 3' (i.e., the
most proximal) V-region genes. An examination of Table 2
indicates that there has been sufficient shuffling of genes to
randomly associate nearly all of the V-region segments with
the C-region genes. It is therefore logical to expect that a
disease-susceptibility locus located amongst the V-region
genes would also be randomly associated with C-region
V 8 V, 11 V 15 C
240 kb 180kb I <20kb1 <8 kb
Bgl Kpn
+ + +_-
FIG. 2. Organization of TCRJ3 polymorphisms used in this study as determined by Lai et al. (7), Perl et al. (30), and unpublished data. The
conclusions of linkage disequilibrium between adjacent RFLPs (based on Table 2) are summarized as presence (+) or absence (-) of significant
linkage disequilibrium (see Table 2 legend). The V,88/BamHl polymorphism is located near the V,08.1-V,38.3 gene cluster as opposed to the
Vp8.4-Vp8.5 gene cluster, based on relative hybridization strengths (data not shown). The order of the V,67/BamHI and EcoRV polymorphisms
has not been determined by physical mapping techniques.
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Table 3. Most efficient strategy for achieving maximum heterozygosity at the TCRf3 locus, based
on empirical data
No. of
enzymes % observed
examined heterozygosity Best combination of restriction enzymes
1 82.4 BamHI
2 91.9 BamHI/Bgl II
3 97.3 BamHI/Bgl lI/Kpn I
4 97.3 BamHI/Bgl II/Kpn I/EcoRV
or BamHI/Bgl II/Kpn I/Taq I
or BamHI/Bgl II/Kpn I/Msp I
5 97.3 BamHI/Bgl II/Kpn I/EcoRV/Taq I
or BamHI/Bgl II/Kpn I/EcoRV/Msp I
or BamHI/Bgl II/Kpn I/Taq I/Msp I
6 97.3 BamHI/Bgl II/Kpn I/EcoRV/Taq I/Msp I
All possible sets of restriction enzymes noted to detect RFLPs (Table 1) were tested by a computer
program for the frequency of heterozygosity in the CEPH parents. Note that BamHI restriction enzyme
digests can reveal heterozygosity at Vp7, Vp8, or Vp11, while all other enzyme digests could only be
scored as heterozygous with one TCR,8 probe tested (Table 1).
RFLPs. Second, because of the random association between
most of the V-region gene segments, disease association
studies performed on a population-versus-population basis
should measure several TCR8 RFLPs dispersed throughout
the V-region genes for which linkage disequilibrium relation-
ships are known before conclusions are reached about
whether a disease-associated locus exists within this region.
In this regard, it would be helpful to identify a novel RFLP
located between the polymorphic Vs1 and V,8 genes that is
in linkage disequilibrium with both of these polymorphisms
(see Fig. 2). This would create a contiguous set of polymor-
phisms in linkage disequilibrium that span more than 600 kb
of the TCR8 gene complex, a valuable research tool for
investigating the role of the TCRB genes in human disease.
Lastly, the presence of linkage equilibrium between some
TCR,8 markers predicts that portions of the TCRP3 gene
complex to either side of an established susceptibility locus
may be excluded from containing the susceptibility locus by
noting linkage equilibrium between the disease and a DNA
polymorphism. We have recently taken this approach for
further localizing a multiple sclerosis-susceptibility gene
within the TCR8 gene complex (ref. 16 and unpublished
data).
For studies that compare the proportion of affected and
unaffected siblings sharing TCRP haplotypes (i.e., sib-pair
analysis), as well as for genetic linkage studies, it is imper-
ative that at least one of the two parents of the affected
individuals be heterozygous. For this purpose, we have used
our extensive TCR/3 data base to empirically determine the
most efficient experimental design for achieving heterozy-
gosity. Hybridizing three blots (BamHI, BgI II, and Kpn I
digests) in addition to using probes that span more than 600
kb of the TCR,3 gene complex, provided maximum heterozy-
gosity (97.3%). The optimum choice ofthese three restriction
enzyme digests to detect four RFLPs is accounted for by our
observation that each of the remaining three polymorphisms
is in significant linkage disequilibrium with one of the four
RFLPs studied. However, as discussed above, all of these
polymorphisms may be useful for population-based disease
association studies, for example, after it has been established
by sib-pair analysis that there is evidence for a disease-
susceptibility locus within the TCR8 complex.
The high level of heterozygosity achieved with RFLPs also
allows detection of unmapped genes within or beyond the
TCR,8 gene complex. Through the use of the TCR/8 haplo-
types in a genetic linkage analysis, we obtained significant lod
scores of linkage between TCRP and DNA markers up to
approximately 30 cM to either side of the TCRp complex. By
virtue ofthe informativeness ofthe TCRP haplotype, it is also
possible to statistically exclude (lod < -2.0) unlinked mark-
ers from the region surrounding the TCR, locus. The TCRB
RFLPs will therefore be useful in the continuing effort to
construct a high-resolution genetic map in humans.
To summarize, this report on RFLPs within the TCRf3 gene
complex should be useful for other studies that hypothesize
disease-susceptibility loci in the vicinity of this gene com-
plex. The identification of specific regions of linkage dis-
equilibrium among these RFLPs should assist in the design of
population-versus-population-based TCRp/disease associa-
tion studies. These results point out the necessity of using
polymorphisms across the entire TCR,3 complex, due to
linkage equilibrium within the gene complex. Our recom-
mendations regarding how to most efficiently detect TCRP
heterozygosity should also hasten sib-pair analyses ofTCR"
involvement in disease pathogenesis. Based on the growing
number of recent reports suggesting that TCR,8 germ-line
Odds: 307:1 7x105:1 3x1Cd:1
Locus: MET D7S71 D7S93 D7S 107 D7S91 TCRB D7S56 D7S 104 qter
Theta: 0o.i 0.03 0o04 0.09 0.06 0.04 0.27
Odds: 2x1l6:1 2036:1 9xld:1 1:271
FIG. 3. Genetic map of markers surrounding the TCR8 complex on chromosome 7q, showing the "most likely" order and the
sex-independent recombination rates between DNA markers that showed significant linkage (lod > 3) with the TCR,8 gene complex (ranging
from 6.8 to 29.4). Recombination fraction estimates (theta) are shown between adjacent loci. The odds against inversion of adjacent loci are
shown above or below the brackets. The names of the loci detected with anonymous single-copy DNA segments are listed according to their
official symbol names (32).
Proc. Natl. Acad. Sci. USA 87 (1990)
Proc. Natl. Acad. Sci. USA 87 (1990) 4827
DNA polymorphisms may be associated with human autoim-
mune diseases (13-20), our observations concerning haplo-
typing the TCRI3 complex by use of RFLPs will hopefully
provide a timely source reference.
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